S
BHVN

SignatureFD’s Biohaven Pharmaceutical Holding Company Ltd. BHVN Stock Holding History

SignatureFD’s Portfolio BHVN Stock Details BHVN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-362
Closed -$55K – 3480
2022
Q3 		$55K Buy
362
+235
+185% +$34.8K ﹤0.01% 1228
2022
Q2 		$19K Buy
127
+84
+195% +$10.7K ﹤0.01% 1818
2022
Q1 		$5K Buy
43
+33
+330% +$4.12K ﹤0.01% 2543
2021
Q4 		$1K Buy
+10
New +$1.27K ﹤0.01% 3078
2021
Q1 		– Sell
-15
Closed -$1K – 2895
2020
Q4 		$1K Buy
+15
New +$1.27K ﹤0.01% 2535
2020
Q3 		– Sell
-75
Closed -$5K – 2859
2020
Q2 		$5K Buy
+75
New +$3.99K ﹤0.01% 1856

Other funds holding BHVN

LIP
Liontrust Investment Partners London, United Kingdom $5.86B AUM 23.75% 1-Year Est. Return
KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
BC
Birchview Capital Burlington, Vermont $176M AUM 95.04% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return
FIA
FNY Investment Advisers New York $278M AUM 98.95% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
MSCM
McElhenny Sheffield Capital Management Dallas, Texas $404M AUM 19.8% 1-Year Est. Return

SignatureFD's BHVN Position: Q4 2022 in Review

SignatureFD sold out of Biohaven Pharmaceutical Holding Company Ltd. (BHVN) in Q4 2022, closing a stake of 362 shares — an estimated $55K sold.

SignatureFD first reported a position in BHVN in Q2 2020 and held it in 6 quarters. The position peaked at $55K in Q3 2022. 7 funds tracked by Wall St. Rank hold BHVN as of Q4 2022.

  • SignatureFD reported no remaining Biohaven Pharmaceutical Holding Company Ltd. position as of Q4 2022 after selling out during the quarter.
  • SignatureFD sold 362 Biohaven Pharmaceutical Holding Company Ltd. shares in Q4 2022, an estimated $55K.
  • SignatureFD first reported a position in Biohaven Pharmaceutical Holding Company Ltd. in Q2 2020 and held it in 6 quarters.
  • SignatureFD's Biohaven Pharmaceutical Holding Company Ltd. position peaked at $55K in Q3 2022.
  • 7 funds tracked by Wall St. Rank held Biohaven Pharmaceutical Holding Company Ltd. as of Q4 2022.

Based on SignatureFD's 13F filing for Q4 2022, filed 30 Jan 2023.